Cargando…
Glucose-6-Phosphate Dehydrogenase Deficiency-Associated Hemolytic Anemia and Methemoglobinemia in a Patient Treated With Hydroxychloroquine in the Era of COVID-19
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymatic disorder of red blood cells worldwide. The severity of hemolytic anemia varies among individuals with G6PD deficiency, depending on the genetic variant in the G6PD gene; this makes the diagnosis of the condition more ch...
Autores principales: | Laslett, Nicole, Hibbs, Julianne, Hallett, Max, Ghaneie, Arezoo, Zemba-Palko, Vlasta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223605/ https://www.ncbi.nlm.nih.gov/pubmed/34178542 http://dx.doi.org/10.7759/cureus.15232 |
Ejemplares similares
-
HEMOLYTIC ANEMIA AND METHEMOGLOBINEMIA DUE TO HYDROXYCHLOROQUINE USE FOR COVID-19 TREATMENT IN A GLUCOSE-6-PHOSPHATE DEHYDROGENASE-DEFICIENT PATIENT
por: Lim, Steven, et al.
Publicado: (2020) -
Naphthalene-Induced Acute Oxidative Hemolysis With Methemoglobinemia in Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency
por: Thangatorai, Ramesh
Publicado: (2022) -
Refractory Methemoglobinemia Secondary to Topical Dapsone With Subsequent Autoimmune Hemolytic Anemia
por: Cantrell, Catharine, et al.
Publicado: (2022) -
Vancomycin-Induced Hemolytic Anemia
por: Siddiqui, Fakeha, et al.
Publicado: (2023) -
Cytomegalovirus and Hemolytic Anemia in an Immunocompetent Adult
por: Ferrão, Diana, et al.
Publicado: (2022)